International Biotechnology (IBT) Share Price, News & Analysis GBX 599.28 -8.72 (-1.43%) (As of 07:36 AM ET) Add Compare Share Share Today's Range 598▼ 60850-Day Range 548▼ 666.7752-Week Range 548▼ 744Volume25,918 shsAverage Volume48,059 shsMarket Capitalization£234.56 millionP/E Ratio570.74Dividend Yield4.67%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisChartCompetitorsDividendHeadlinesInsider Trades About International Biotechnology Stock (LON:IBT)International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.Read More IBT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBT Stock News HeadlinesDecember 4, 2023 | tmcnet.comGlobal Bio-India 2023 attracts global interest for India's $300 billion biotech potential from companies, academia, and start-upsNovember 30, 2023 | msn.com4Moving Biotech shares innovative trial plans for GLP-1 osteoarthritis drugDecember 11, 2023 | Financial Alphas (Ad)Lithium Discovery So BIG You Can't Miss it, Even From SpaceWith the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!November 30, 2023 | markets.businessinsider.comCABIO unveils NeoHMOs™ series at FIE 2023, targeting growing global demand for infant formulaNovember 29, 2023 | msn.comBharat Biotech Collaborates With University Of Sydney For Vaccine Research CollaborationSeptember 21, 2023 | msn.comBharat Biotech nears phase III trials for tuberculosis vaccineSeptember 13, 2023 | au.finance.yahoo.comInternational Biotechnology Ord (IBT.L)July 20, 2023 | wsj.comTCM Biotech International Corp.December 11, 2023 | Financial Alphas (Ad)Lithium Discovery So BIG You Can't Miss it, Even From SpaceWith the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!July 10, 2023 | uk.movies.yahoo.comHardman & Co Research on International Biotechnology Trust (IBT): Industry M&A remains a key driverJuly 3, 2023 | wsj.comBiotech CEO Gets Hands-On After Cyberattack to Protect BusinessMay 27, 2023 | finance.yahoo.comIBT.L - International Biotechnology Trust plcApril 25, 2023 | msn.comUS consumer confidence falls to 9-month low in AprilFebruary 14, 2023 | lse.co.ukSV Health notifies International Biotechnology of termination in 2024February 13, 2023 | lse.co.ukSMALL-CAP WINNERS & LOSERS: Non-Standard drops on insolvency warningDecember 8, 2022 | uk.finance.yahoo.comHardman & Co Research on International Biotechnology Trust (IBT): Low FDA activity may drive further M&ANovember 10, 2022 | msn.comWe’re confident healthcare stocks will recover, so investors should buy these fundsSeptember 6, 2022 | reuters.comBharat Biotech's COVID-19 nasal vaccine approved for restricted use in IndiaJuly 3, 2022 | thetimes.co.ukOur expanding waistbands may stop me from having to tighten my beltJune 30, 2022 | uk.finance.yahoo.comHardman & Co Research: International Biotechnology Trust (IBT) - M&A activity on the riseJanuary 3, 2022 | thetimes.co.ukIan Cowie: Five investment reasons to be cheerfulDecember 4, 2021 | finanznachrichten.deHardman & Co Research: International Biotechnology Trust (IBT) - Access to fast-growing biotechnology companiesDecember 3, 2021 | uk.finance.yahoo.comHardman & Co Research : International Biotechnology Trust (IBT) - Access to fast-growing biotechnology companiesNovember 4, 2021 | lse.co.ukInt.biotech. Share ChatOctober 27, 2021 | uk.finance.yahoo.comInternational Biotechnology Trust plc (IBT.L)September 2, 2021 | wsj.comTrade-Van Information Services Co. Ltd.August 6, 2021 | prnewswire.comTeamsters Local 533 On Strike Against RTC Washoe Bus Contractor Keolis TransitSee More Headlines Receive IBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON Industry Asset Management Sub-IndustryN/A SectorFinancial Services Current SymbolLON:IBT CUSIPN/A CIKN/A Webwww.ibtplc.com Phone44 20 7421 7070FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 1.05 Trailing P/E Ratio579.05 Forward P/E Ratio726.23 P/E GrowthN/ANet Income£43.12 million Net Margins84.61% Pretax MarginN/A Return on Equity15.33% Return on Assets9.20% Debt Debt-to-Equity Ratio8.19 Current Ratio0.27 Quick Ratio0.32 Sales & Book Value Annual Sales£50.96 million Price / Sales4.67 Cash FlowGBX 3.90 per share Price / Cash Flow155.74 Book ValueGBX 725 per share Price / Book0.84Miscellaneous Outstanding Shares39,140,000Free FloatN/AMarket Cap£237.97 million OptionableNot Optionable Beta0.18 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMs. Catherine Elizabeth Bingham M.B.A. (Age 57)Managing Partner Ms. Ailsa CraigInvestment ManagerMr. Marek Poszepczynski M Sci EngInvestment ManagerClaire JacksonCompany SecretaryMr. Hari SabharwalFund ControllerDr. Carl Harald JansonLead Investment ManagerMore ExecutivesKey CompetitorsJPMorgan US Smaller CompaniesLON:JUSCabrdn Diversified Income & GrowthLON:ADIGCC Japan Income & GrowthLON:CCJIabrdn New DawnLON:ABDCurtis Banks GroupLON:CBPView All CompetitorsInsidersCaroline GulliverBought 2,500 shares on 11/7/2023Total: £1.43 M ($573.00/share)Katherine Cornish-BowdenBought 1,500 shares on 8/3/2023Total: £949,500.00 ($633.00/share)View All Insider Transactions IBT Stock Analysis - Frequently Asked Questions How have IBT shares performed in 2023? International Biotechnology's stock was trading at GBX 706 on January 1st, 2023. Since then, IBT shares have decreased by 15.1% and is now trading at GBX 599.28. View the best growth stocks for 2023 here. How often does International Biotechnology pay dividends? What is the dividend yield for International Biotechnology? International Biotechnology announced a dividend on Wednesday, July 5th. Investors of record on Thursday, July 27th will be paid a dividend of GBX 14.20 per share on Friday, August 25th. This represents a yield of 2.15%. The ex-dividend date is Thursday, July 27th. This is a boost from the stock's previous dividend of GBX 14. The official announcement can be accessed at this link. Read our dividend analysis for IBT. Is International Biotechnology a good dividend stock? International Biotechnology (LON:IBT) pays an annual dividend of GBX 28 per share and currently has a dividend yield of 5.18%. IBT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 2,666.67%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for IBT. What other stocks do shareholders of International Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some companies that other International Biotechnology investors own include Oxford Pharmascience Group (OXP), Vanquis Banking Group (PFG), 1724525 (ADN.L) (ADN), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR), Phoenix Group (PHNX), Riverstone Energy (RSE), Scirocco Energy Plc (SOLO.L) (SOLO) and Sirius Minerals (SXX). How do I buy shares of International Biotechnology? Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:IBT) was last updated on 12/11/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.